Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 39Neoplasms 37Depression 29Prostatic Neoplasms 23Fatigue 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Multiple Myeloma 15Lymphoma, Follicular 15Lymphoma, Large B-Cell, Diffuse 13Carcinoma, Non-Small-Cell Lung 13Anxiety Disorders 13Lymphoma, Mantle-Cell 12Leukemia, Lymphocytic, Chronic, B-Cell 12Burkitt Lymphoma 12Pain 11Lymphoma, Non-Hodgkin 11Lymphoma, B-Cell, Marginal Zone 11Lung Neoplasms 11Lymphoma, Large-Cell, Immunoblastic 10Leukemia, Myeloid, Acute 10Colorectal Neoplasms 10Leukemia, Myeloid, Chronic-Phase 9Hodgkin Disease 9Blast Crisis 9Vomiting 8Nausea 8Lymphoma 8Leukemia, Myeloid, Accelerated Phase 8Head and Neck Neoplasms 8Uterine Cervical Neoplasms 7

Interventions

pembrolizumab 7Nivolumab 5durvalumab 3fludarabine 2avelumab 2atezolizumab 2Cyclophosphamide 2tremelimumab 1relatlimab 1fludarabine phosphate 1epacadostat 1bintrafusp alfa protein, human 1aldesleukin 1Therapeutics 1Temozolomide 1Surgical Procedures, Operative 1Oxaliplatin 1Neoadjuvant Therapy 1Ipilimumab 1Interleukin-2 1Injections 1Immunoglobulin G 1Educational Status 1Docetaxel 1Disulfides 1Chemotherapy, Adjuvant 1Capecitabine 1Bevacizumab 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Microsatellite Instability × Therapeutics × Clear all
NCT03519412 2026-03-03

ARETHUSA

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 2 Completed
107 enrolled 14 charts
Gastrointestinal

Colorectal Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡